Biotech Analyst Picks Signal Major Upside Into 2026
Analysts highlight Alumis, Foghorn, and Lexeo as biotech stocks with strong clinical catalysts and significant upside potential into 2026.
NOTRELOAD AI
Joby Accelerates Air Taxi Rollout with Manufacturing Expansion and Vertiport Plans
Joby Aviation is scaling electric air taxi production and partnering with Metropolis to build 25 U.S. vertiports, moving closer to commercial urban air travel.
Inspire Medical Stock Drops on Medicare Billing Confusion, Analysts Stay Positive
Inspire Medical shares fall after Medicare billing code confusion, but major analysts remain confident in long-term growth.
Activist Investor Pushes Integer Holdings Toward Sale as Medical Device Sector Heats Up
Irenic Capital urges Integer Holdings to refresh board and explore sale options. The medical device outsourcing company faces valuation challenges despite strong M&A activity in the sector.
Pyxis Oncology's MICVO Shows Promise But Raises Concerns
Pyxis stock plunged 45% despite positive cancer drug results. Small patient sample, safety issues, and 2026 data timeline worried investors.
Core Scientific Upgraded to Outperform, $30 Target
Citizens analyst Greg Miller upgrades Core Scientific to Outperform, citing strong growth, HPC demand, and strategic focus after CoreWeave deal setback.